Updated safety results from a cohort compassionate-use programme (CUP) and early access programme (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D)
| dc.contributor.author | Ardavanis, A. | |
| dc.contributor.author | Basaran, M. | |
| dc.contributor.author | Malik, Z. I. | |
| dc.contributor.author | Di Lorenzo, G. | |
| dc.contributor.author | Heidenreich, A. | |
| dc.contributor.author | Hitier, S. | |
| dc.contributor.author | Van Oort, I. | |
| dc.contributor.author | Saad, F. | |
| dc.contributor.author | De Schultz, W. | |
| dc.contributor.author | Parente, P. | |
| dc.date.accessioned | 2021-03-03T17:16:33Z | |
| dc.date.available | 2021-03-03T17:16:33Z | |
| dc.identifier.citation | Malik Z. I. , Di Lorenzo G., Ardavanis A., Basaran M., Parente P., De Schultz W., Saad F., Van Oort I., Hitier S., Heidenreich A., "Updated safety results from a cohort compassionate-use programme (CUP) and early access programme (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D)", European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_48e429d6-5f9d-4ca3-b5bc-574aba2c3acb | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/52463 | |
| dc.language.iso | eng | |
| dc.subject | Onkoloji | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.title | Updated safety results from a cohort compassionate-use programme (CUP) and early access programme (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D) | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 49 | |
| dc.contributor.firstauthorID | 142531 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]